Arcadia Biosciences, Inc. — Director's Dealing 2016

Aug 22, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2016-08-18

Reporting Person: Shah Rajiv (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-18	Stock Option (right to buy)	$2.14	A	18112	Acquired	2026-08-17	Common Stock (18112)	Direct

Footnotes

F1: The option will become 100% vested and exercisable on the earlier to occur of (i) August 18, 2017 or (ii) the date of the Issuer's next Annual Meeting of Stockholders.